| 1. |
Cyclic AMP
|
AKT1
|
Cyclic AMP inhibits the reaction [FGF2 results in increased activity of AKT1] |
1 |
1 |
| 2. |
AICA ribonucleotide
|
AKT1
|
AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in decreased oxidation of Fatty Acids] |
1 |
1 |
| 3. |
AICA ribonucleotide
|
AKT1
|
AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased phosphorylation of EIF4EBP1 protein] |
1 |
1 |
| 4. |
AICA ribonucleotide
|
AKT1
|
AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] |
1 |
1 |
| 5. |
AICA ribonucleotide
|
AKT1
|
PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]] |
1 |
1 |
| 6. |
Azacitidine
|
AKT1
|
Azacitidine inhibits the reaction [TGFB1 protein results in increased phosphorylation of AKT1 protein] |
1 |
1 |
| 7. |
8-Bromo Cyclic Adenosine Monophosphate
|
AKT1
|
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AKT1 mRNA |
1 |
1 |
| 8. |
Zalcitabine
|
AKT1
|
Zalcitabine affects the phosphorylation of AKT1 protein |
1 |
1 |
| 9. |
decitabine
|
AKT1
|
AKT1 protein inhibits the reaction [decitabine results in increased expression of TNFSF10 protein] |
1 |
1 |
| 10. |
decitabine
|
AKT1
|
decitabine results in decreased activity of AKT1 protein |
2 |
1 |
| 11. |
decitabine
|
AKT1
|
decitabine results in increased phosphorylation of AKT1 protein |
1 |
1 |
| 12. |
fludarabine
|
AKT1
|
fludarabine results in decreased phosphorylation of and results in decreased activity of AKT1 protein |
1 |
1 |
| 13. |
fludarabine
|
AKT1
|
fludarabine results in increased activity of AKT1 protein |
1 |
1 |
| 14. |
gemcitabine
|
AKT1
|
AKT1 protein affects the susceptibility to gemcitabine |
1 |
1 |
| 15. |
Cyclic GMP
|
AKT1
|
AKT1 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Cyclic GMP] |
1 |
1 |
| 16. |
N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
|
AKT1
|
Pertussis Toxin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of AKT1 protein] |
1 |
1 |
| 17. |
N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
|
AKT1
|
wortmannin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of AKT1 protein] |
1 |
1 |
| 18. |
(N)-methanocarba-2MeSADP
|
AKT1
|
ADRBK1 protein inhibits the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of and results in increased activity of AKT1 protein] |
1 |
1 |
| 19. |
(N)-methanocarba-2MeSADP
|
AKT1
|
(N)-methanocarba-2MeSADP results in increased phosphorylation of AKT1 protein |
1 |
1 |
| 20. |
(N)-methanocarba-2MeSADP
|
AKT1
|
PRKCZ protein inhibits the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of and results in increased activity of AKT1 protein] |
1 |
1 |
| 21. |
(N)-methanocarba-2MeSADP
|
AKT1
|
RAP1GAP protein inhibits the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of and results in increased activity of AKT1 protein] |
1 |
1 |
| 22. |
triciribine
|
AKT1
|
triciribine results in decreased phosphorylation of AKT1 protein |
1 |
1 |